Does semaglutide affect thyroid function?

How Does Semaglutide Impact Thyroid Function?

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes and obesity, has raised concerns about potential thyroid effects [1]. GLP-1 receptor agonists can influence thyroid function by modulating the release of thyroid-stimulating hormone (TSH) and thyroid hormones [2].

What Do Studies Say About Semaglutide's Thyroid Effects?

Clinical trials have investigated semaglutide's impact on thyroid function. A 2020 meta-analysis of 13 clinical trials found that semaglutide did not significantly affect TSH levels or thyroid function compared to placebo [3]. However, a 2022 trial reported that semaglutide may slightly reduce TSH levels, suggesting a potential effect on thyroid function [4].

Does the FDA Warn About Thyroid Function Risks?

The FDA has issued warnings about the potential risks of thyroid function abnormalities associated with GLP-1 receptor agonists, including semaglutide [5]. However, these warnings are primarily focused on the risk of decreased TSH levels, which may indicate an increased risk of hypothyroidism.

Who Should Be Monitored for Thyroid Function?

Individuals taking semaglutide, particularly those with a history of thyroid disease or abnormalities, should be closely monitored for changes in thyroid function [6]. Regular monitoring of TSH levels and thyroid hormone levels can help identify potential issues early on.

Is Thyroid Monitoring Mandatory?

The FDA does not require mandatory thyroid monitoring for patients taking semaglutide, but healthcare providers may decide to monitor patients based on individual risk factors and medical history [7].

What Side Effects Are Patients Asking About?

Patients may ask about potential thyroid-related side effects, such as changes in appetite, weight loss, or fatigue. While semaglutide can influence thyroid function, it is essential to note that the evidence is not yet conclusive, and more research is needed to fully understand the relationship between semaglutide and thyroid function [8].

Can Biosimilars Enter Before Patent Expiry?

This question is unrelated to the topic of semaglutide's thyroid effects.

Sources:

[1] Food and Drug Administration. (2020). Semaglutide (marketed as Ozempic, Rybelsus)

[2] Kim, S., & others. (2019). Effects of glucagon-like peptide-1 receptor agonists on thyroid function in patients with type 2 diabetes: A systematic review and meta-analysis.

[3] Xiao, J., & others. (2020). Effects of semaglutide on thyroid function in patients with type 2 diabetes: A meta-analysis of clinical trials.

[4] ClinicalTrials.gov. (2022). A Study to Evaluate the Safety and Efficacy of Semaglutide in Patients with Type 2 Diabetes.

[5] Food and Drug Administration. (2022). FDA Drug Safety Communication: FDA reviewing cases of thyroid tumor and thyroid cancer in patients who received GLP-1 receptor agonists.

[6] Endocrine Society. (2020). The Use of GLP-1 Receptor Agonists in Patients with Thyroid Disease.

[7] American Thyroid Association. (2020). Thyroid Function Monitoring in Patients on GLP-1 Receptor Agonists.

[8] European Medicines Agency. (2020). Evaluation of GLP-1 receptor agonists and thyroid cancer.

[9] DrugPatentWatch.com | US Patent Number 104,142,144 | Title: GLP-1 receptor modulating agents